Omega-3 fatty acids and major depression: a Mendelian randomization study

Area of Science:

• Nutritional Neuroscience
• Psychiatric Genetics
• Metabolic Epidemiology

Background:

• Omega-3 fatty acids are linked to depression, but prevention trials have been unsuccessful.
• The causal relationship between omega-3s and major depressive disorder (MDD) remains unclear.

Purpose of the Study:

• To investigate the causal role of omega-3 and omega-6 fatty acids in the aetiology of major depressive disorder (MDD) and recurrent MDD (rMDD).
• To explore the specific contributions of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) to depression risk.

Main Methods:

• Two-sample Mendelian randomization (MR) using genetic variants from UK Biobank (exposures) and Psychiatric Genomics Consortium (outcomes).
• Multivariable MR (MVMR) to adjust for correlated lipids and identify key omega-3 fatty acids (EPA, DHA).
• Genetic colocalization analyses to assess shared causal variants.

Main Results:

• Genetically predicted total omega-3 fatty acids were associated with reduced odds of MDD (OR_IVW 0.96).
• Eicosapentaenoic acid (EPA) showed the strongest protective effect (OR_EPA 0.92).
• Results were robust to MVMR and highlighted the FADS gene cluster; colocalization suggested shared causal variants, though confounding was possible.

Conclusions:

• Omega-3 fatty acids, particularly EPA, support a role in the aetiology of depression.
• Findings suggest targeted interventions focusing on EPA may be more effective than universal prevention for MDD.
• Further research is needed to fully elucidate mechanisms and rule out pleiotropic effects.